glucagon has been researched along with Kidney Failure, Chronic in 99 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 71 (71.72) | 18.7374 |
| 1990's | 17 (17.17) | 18.2507 |
| 2000's | 1 (1.01) | 29.6817 |
| 2010's | 7 (7.07) | 24.3611 |
| 2020's | 3 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, MK; Galindo, RJ; Inselman, SA; McCoy, RG; Moazzami, B; Munoz Mendoza, J; Tuttle, KR; Umpierrez, GE | 1 |
| Abe, M; Kitai, M; Kobayashi, H; Maruyama, T; Takao, N; Takashima, H; Yoshida, Y | 1 |
| Brandi, L; Bressendorff, I; Feldt-Rasmussen, B; Hansen, HP; Hartmann, B; Holst, JJ; Hornum, M; Idorn, T; Jørgensen, MB; Knop, FK; Rydahl, C; van Hall, G; Wewer Albrechtsen, NJ | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Broberg, B; Christensen, KB; Feldt-Rasmussen, B; Fuglsang, S; Holst, JJ; Hornum, M; Idorn, T; Madsen, JL; Rydahl, C | 1 |
| Benitez, JG; Hoot, NR; Palm, KH | 1 |
| Feldt-Rasmussen, B; Holst, JJ; Hornum, M; Idorn, T; Jørgensen, M; Knop, FK | 2 |
| Bojsen-Møller, KN; Deacon, CF; Feldt-Rasmussen, B; Hartmann, B; Holst, JJ; Idorn, T; Knop, FK; Madsbad, S; Plamboeck, A; Veedfald, S; Vilsbøll, T; Wewer Albrechtsen, NJ; Windeløv, JA | 1 |
| Feldt-Rasmussen, B; Holst, JJ; Hornum, M; Idorn, T; Jørgensen, MB; Knop, FK | 1 |
| Cerletty, JM; Engbring, NH | 1 |
| Buerklin, E; Eisen, C; Goldberg, M; Grabie, M; Murray, TG; Walker, BR | 1 |
| Bia, MJ; DeFronzo, RA | 1 |
| Furukawa, Y; Goto, Y; Inui, M; Ishimori, A; Kameyama, J; Komatsu, K; Nakanome, C; Sasaki, I; Yamazaki, T | 1 |
| Alvestrand, A; Bergström, J | 1 |
| Marumo, F; Sakai, T; Shirataka, M | 1 |
| Finidori, J; Kleinknecht, C; Postel-Vinay, MC | 1 |
| Marcén, R; Matesanz, R; Orofino, L; Ortuño, J; Quereda, C | 1 |
| Marumo, F; Nango, H; Sakai, T; Shirataka, M | 1 |
| Schoeppe, W; Vlachoyannis, J | 1 |
| Arem, R; Field, JB; Garber, AJ | 1 |
| Alberti, KG; Burrin, JM; Heaton, A; Johnston, DG; Kerr, DN; Orskov, H; Ward, MK | 1 |
| Kitaji, J; Rabkin, R | 1 |
| Kokot, F; Mleczko, Z; Wnuk, R | 1 |
| Jarkovský, L | 1 |
| Ardaillou, R; Paillard, F | 1 |
| Emmanouel, DS; Katz, AI; Lindheimer, MD | 1 |
| Chantler, C | 1 |
| Dubernard, JM; Malik, MC; Ruitton, AM; Touraine, JL; Traeger, J | 1 |
| Bergström, J; Karlander, SG; Lindholm, B | 1 |
| Czekalski, S; Gołebiowska, I; Gryczyńska, M; Nowotko, U; Słuczanowski, W; Toczkowski, M | 1 |
| Buchanan, KD; Flanagan, RW; Murphy, RF | 1 |
| Eidemak, I; Feldt-Rasmussen, B; Kanstrup, IL; Nielsen, SL; Schmitz, O; Strandgaard, S | 1 |
| Fouque, D; Kopple, JD; Peng, SC | 1 |
| Chagnac, A; Gafter, U; Hirsh, J; Korzets, A; Levi, J; Weinstein, T; Zevin, D | 1 |
| Battezzati, A; Bianchi, E; Di Carlo, V; Luzi, L; Perseghin, G; Pozza, G; Secchi, A; Spotti, D; Vergani, S | 1 |
| Castelluccio, A; Fiorini, F; Patrone, E; Raffa, M | 1 |
| Arfeen, S; Channon, S; Goodship, TH; Kirkwood, A; Ward, MK | 1 |
| Baartz, A; Baartz, T; Becker, HD; Büsing, M; Creutzfeldt, W; Hopt, UT; Nauck, MA; Orskov, C; Siegel, EG; Talartschik, J | 1 |
| Benz, S; Erb, M; Gwodzinski, A; Hopt, UT; Nauck, MA; Pfeffer, F | 1 |
| Barreca, T; Bruno, E; Cataldi, A; Corsini, G; Franceschini, R; Robaudo, C; Rolandi, E; Russo, R | 1 |
| Askari, H; Dagogo-Jack, S; Franklin, SC; Liu, J; Miller, SB; Vijayan, A | 1 |
| Forster, D; Fuhrmann, C; Holland, MR; Jackson, MA; Lodwick, R; Macdonald, IA; Nicholas, J; Spencer, H; Talbot, M | 1 |
| Abitbol, C; Berkovitz, G; Eidson, M; Leal, D; Seeherunvong, T; Seeherunvong, W | 1 |
| Fricke, L; Heidland, A; Hempel, K; Schmidt, G | 1 |
| Emmanouel, DS; Huen, A; Jaspan, JB; Katz, AI; Kuku, SF; Locker, JD; Rubenstein, AH | 1 |
| Valverde, I | 1 |
| Accary, JP; Mignon, M; Soulé, JC | 1 |
| Jaspan, JB; Rubenstein, AH | 1 |
| Casado, S; Egido, J; Hernando, L; Matesanz, R; Nuño, J; Plaza, JJ | 1 |
| Amici, A; Pappalardo, G; Polli, F | 1 |
| Emmanouel, DS; Katz, AI | 1 |
| Marumo, F; Sakai, T; Sato, S | 1 |
| Hansky, J | 1 |
| Casado, S; Hernando, L; Matesanz, R; Valverde, I | 1 |
| Bloomer, HA; Jubiz, W; O'Neill, WM; Ramirez, G | 1 |
| Caron, C; Langlois, M; Nawar, T; Robert, G | 1 |
| Hayakawa, H; Kawai, K; Morita, N | 1 |
| Heuck, CC; Liersch, M; Mehls, O; Ritz, E; Stegmeier, K; Wirth, A | 1 |
| Bloom, SR; Chantler, C; Counahan, R; El-Bishti, MM | 1 |
| Avram, MM; Carter, AC; Delano, BG; Frank, WM; Friedman, EA; Manis, T; Saxena, AK; Sreepada Rao, TK | 1 |
| Abiko, T; Dazai, S; Ishizaki, M; Kumikawa, M; Sekino, H; Takahashi, H; Uno, C | 1 |
| Ardill, J; Buchanan, KD; Doherty, CC; McGeown, MG | 1 |
| Ducros, J; Mahfoud, A; Olmer, M; Vague, P | 1 |
| Dabels, J; Holldorf, L; Krüger, M; Pietsch, P; Schwähn, D | 1 |
| Bastl, C; Felig, P; Finkelstein, FO; Hayslett, JP; Hendler, R; Sherwin, R | 1 |
| Avram, MM; Carter, AC; Delano, BG; Frank, W; Friedman, EA; Manis, T; Rao, TK; Saxena, AK | 1 |
| Emmanouel, DS; Jaspan, JB; Katz, AI; Kuku, SF; Rubenstein, AH; Zeidler, A | 1 |
| Valverde, I; Villanueva, ML | 1 |
| Atkins, C; Bilbrey, GL; Faloona, GR; Hull, AR; Knochel, JP; White, MG | 1 |
| Emmanouel, DS; Katz, AI; Kuku, SF; Rubenstein, AH; Zeidler, A | 1 |
| Andreasen, J; Holst, JJ; Orskov, C | 1 |
| Chikugo, K; Furukawa, Y; Kanda, H; Koga, A; Kouka, K; Nakao, T; Tajima, N | 1 |
| Amiel, C; Blanchet, F; Friedlander, G; Nitenberg, A | 1 |
| Grzeszczak, W; Klin, M; Kokot, F; Wiecek, A; Zukowska-Szczechowska, E | 1 |
| Arfeen, S; Goodship, TH; Kirkwood, A; Ward, MK | 1 |
| Battezzati, A; Castoldi, R; Di Carlo, V; Facchini, F; Ferrari, G; Luzi, L; Pozza, G; Secchi, A; Spotti, D; Staudacher, C | 1 |
| Hagopian, WA; Tager, HS | 1 |
| Duława, J; Grzeszczak, W; Kokot, F | 2 |
| Grzeszczak, W; Kokot, F; Kurzbauer, R; Kuśmierski, S; Nieszporek, T; Szkodny, A; Zukowska-Szczechowska, E | 1 |
| Albertazzi, A; Cappelli, P; Di Paolo, B; Evangelista, M; Spisni, C | 1 |
| Ivić, MA; Stefanović, V | 1 |
| Ando, A; Fujii, M; Fukuhara, Y; Imai, E; Kamada, T; Mikami, H; Noguchi, T; Orita, Y; Tanaka, T; Yamauchi, A | 1 |
| Kazakova, IA; Nasachev, AA; Trusov, VV | 1 |
| Oka, H | 1 |
| Bier, DM; Cryer, PE; Garber, AJ; Pagliara, AS | 1 |
| Pichler, E | 1 |
| Evers, JL; Hobika, GH; Moore, RH; Mostert, JW; Murphy, GP | 1 |
| Evers, JL; Hobika, GH; Moore, RH; Mostert, JW; Murphy, GP; Trudnowski, RJ | 1 |
| Field, JB; Frizzell, M; Larsen, PR | 1 |
| Bilbrey, GL; Faloona, GR; Knochel, JP; White, MG | 1 |
| Jungers, P; Kleinknecht, D; Laudat, MH; Laudat, P; Strauch, G | 1 |
| Assan, R; Derot, M; Tchobroutsky, G | 2 |
| Bersohn, I; Rubenstein, AH; Spitz, IM; Van AS, M | 1 |
| Imbasciati, E; Ponticelli, C; Redaelli, B; Salvadeo, A | 1 |
| Carneiro de Moura, M; Ginestal Cruz, A | 1 |
11 review(s) available for glucagon and Kidney Failure, Chronic
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Extrarenal potassium homeostasis.
Topics: Aldosterone; Animals; Dogs; Epinephrine; Glomerular Filtration Rate; Glucagon; Homeostasis; Humans; Hydrocortisone; Insulin; Kidney; Kidney Failure, Chronic; Male; Norepinephrine; Potassium; Prednisone; Rats; Somatostatin | 1981 |
[Carbohydrate intolerance in renal insufficiency].
Topics: Blood Glucose; Calcium; Carbohydrates; Energy Metabolism; Glucagon; Glucose; Growth Hormone; Humans; Hypersensitivity; Insulin; Kidney; Kidney Failure, Chronic; Parathyroid Hormone; Potassium Deficiency; Receptors, Cell Surface | 1980 |
Renal metabolism of peptide hormones.
Topics: Animals; Arginine Vasopressin; Calcitonin; Glomerular Filtration Rate; Glucagon; Growth Hormone; Hormones; Humans; Insulin; Kidney; Kidney Concentrating Ability; Kidney Failure, Chronic; Kidney Tubules; Parathyroid Hormone; Prolactin | 1983 |
[Metabolic disorders in uremia. II. Glucose].
Topics: Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Hypoglycemia; Insulin; Kidney Failure, Chronic; Somatomedins; Uremia | 1984 |
Pathogenesis of endocrine abnormalities in uremia.
Topics: Animals; C-Peptide; Calcitriol; Clomiphene; Dihydroxycholecalciferols; Female; Follicle Stimulating Hormone; Glomerular Filtration Rate; Glucagon; Gonadotropin-Releasing Hormone; Hormones; Humans; Insulin; Kidney; Kidney Failure, Chronic; Luteinizing Hormone; Male; Metabolic Clearance Rate; Mineralocorticoids; Parathyroid Hormone; Proinsulin; Prolactin; Sexual Dysfunction, Physiological; Thyroid Hormones; Uremia | 1980 |
[Glucose metabolism and chronic renal insufficiency].
Topics: Glucagon; Glucose; Growth Hormone; Humans; Hyperglycemia; Hypoglycemia; Insulin; Insulin Secretion; Kidney Failure, Chronic; Parathyroid Hormone | 1994 |
[Pathophysiological significance of hypergastrinaemia in man (author's transl)].
Topics: Anemia, Pernicious; Calcium; Dietary Proteins; Duodenal Ulcer; Gastric Juice; Gastrins; Gastritis; Glucagon; Humans; Hyperplasia; Intestine, Small; Kidney Failure, Chronic; Pyloric Antrum; Pyloric Stenosis; Secretin; Stomach Neoplasms; Stomach Ulcer; Vagotomy; Zollinger-Ellison Syndrome | 1977 |
[Gastrin: current state of knowledge].
Topics: Digestion; Esophageal Achalasia; Esophagitis, Peptic; Gastric Inhibitory Polypeptide; Gastric Mucosa; Gastrins; Gastritis; Glucagon; Humans; Ileum; Islets of Langerhans; Jejunum; Kidney Failure, Chronic; Liver; Protein Hydrolysates; Pyloric Antrum; Somatostatin; Vagotomy; Vasoactive Intestinal Peptide; Zollinger-Ellison Syndrome | 1978 |
Metabolism of polypeptide hormones by the normal kidney and in uremia.
Topics: Animals; Antigens; C-Peptide; Erythropoietin; Glucagon; Gonadotropins, Pituitary; Humans; Insulin; Kidney; Kidney Failure, Chronic; Luteinizing Hormone; Metabolic Clearance Rate; Molecular Weight; Pancreatic Hormones; Proinsulin; Prolactin; Uremia | 1978 |
[The functional renal reserve].
Topics: Amino Acids; Angiotensin II; Diabetic Nephropathies; Dietary Proteins; Dinoprostone; Dopamine; Glomerular Filtration Rate; Glucagon; Growth Hormone; Humans; Kidney; Kidney Failure, Chronic; Renal Circulation | 1991 |
4 trial(s) available for glucagon and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effect of the Incretin Hormones on the Endocrine Pancreas in End-Stage Renal Disease.
Topics: Adult; Denmark; Double-Blind Method; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Secretion; Islets of Langerhans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2020 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Case-Control Studies; Female; Glucagon; Humans; Injections, Subcutaneous; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Recombinant Proteins; Renal Dialysis | 1995 |
Reduction of insulin resistance by combined kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients.
Topics: Adult; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycated Hemoglobin; Humans; Insulin; Insulin Infusion Systems; Insulin Resistance; Kidney Failure, Chronic; Kidney Transplantation; Male; Pancreas Transplantation; Reference Values | 1990 |
85 other study(ies) available for glucagon and Kidney Failure, Chronic
| Article | Year |
|---|---|
National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013-2017.
Topics: Adult; Diabetes Mellitus; Glucagon; Humans; Kidney Failure, Chronic; Prescriptions; Renal Dialysis | 2023 |
Kinetics of Glucoregulatory Peptide Hormones during Hemodialysis with Cellulose Triacetate and Polysulfone Dialyzers in Patients with Diabetes and End-Stage Kidney Disease.
Topics: Animals; Cattle; Diabetes Mellitus; Glucagon; Humans; Insulin; Insulin, Regular, Human; Kidney Failure, Chronic; Kinetics; Membranes, Artificial; Renal Dialysis | 2023 |
Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Gastrointestinal Motility; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2019 |
Hemodynamically unstable: accidental atenolol toxicity?
Topics: Abdominal Pain; Adult; Antihypertensive Agents; Atenolol; Bradycardia; Female; Gastrointestinal Agents; Glucagon; Humans; Hypotension; Kidney Failure, Chronic; Peritoneal Dialysis; Young Adult | 2013 |
Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
Topics: Adult; Blood Glucose; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Pancreatic Hormones; Postprandial Period | 2014 |
Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?
Topics: Enzyme-Linked Immunosorbent Assay; Gastric Bypass; Glucagon; Humans; Kidney Failure, Chronic | 2014 |
Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diabetes Mellitus; Dialysis Solutions; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Hemodiafiltration; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Postprandial Period; Renal Dialysis; Young Adult | 2015 |
Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease.
Topics: Adult; Analysis of Variance; Area Under Curve; Biomarkers; Blood Glucose; Case-Control Studies; Fasting; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Tract; Glucagon; Glucagon-Like Peptide 1; Glucose Metabolism Disorders; Glucose Tolerance Test; Humans; Incretins; Insulin; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Time Factors | 2013 |
Azotemia and glucose intolerance.
Topics: Adult; Aged; Blood Glucose; Blood Urea Nitrogen; Creatine; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Immunoassay; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Tolbutamide; Uremia | 1967 |
The effect of somatostatin on the hormonal abnormalities of end stage renal disease.
Topics: Adult; Female; Gastrins; Glucagon; Growth Hormone; Hormones; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Somatostatin; Thyrotropin | 1981 |
Clinical significance of glucagon provocation test in the diagnosis of hypergastrinemia.
Topics: Adult; Diagnosis, Differential; Duodenal Ulcer; Female; Gastrectomy; Gastrins; Glucagon; Humans; Kidney Failure, Chronic; Middle Aged; Multiple Endocrine Neoplasia; Pyloric Antrum; Secretin; Stomach Ulcer; Zollinger-Ellison Syndrome | 1981 |
Glomerular hyperfiltration after protein ingestion, during glucagon infusion, and in insulin-dependent diabetes is induced by a liver hormone: deficient production of this hormone in hepatic failure causes hepatorenal syndrome.
Topics: Amino Acids; Animals; Diabetes Mellitus, Type 1; Dietary Proteins; Glomerular Filtration Rate; Glucagon; Glucuronates; Hemodynamics; Humans; Kidney Failure, Chronic; Kidney Glomerulus; Liver; Liver Diseases; Models, Biological | 1984 |
A multivariate factor analysis of the high plasma concentration of cyclic AMP in patients with chronic renal failure.
Topics: Adult; Aged; Blood Urea Nitrogen; Creatinine; Cyclic AMP; Factor Analysis, Statistical; Female; Glucagon; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis; Urea | 1980 |
Lactogenic and somatotropic binding sites in liver membranes of rats with renal insufficiency.
Topics: Animals; Cell Membrane; Creatinine; Disease Models, Animal; Female; Glucagon; Growth Hormone; Insulin; Kidney Failure, Chronic; Liver; Nucleotidases; Prolactin; Rats; Receptors, Cell Surface | 1980 |
[A study on endocrine disorders in patients with chronic renal failure (author's transl)].
Topics: Adrenocorticotropic Hormone; Cyclic AMP; Glucagon; Growth Hormone; Humans; Insulin; Kidney Failure, Chronic; Parathyroid Hormone; Renal Dialysis | 1981 |
Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia.
Topics: Adult; Aged; Blood Glucose; Cyclic AMP; Female; Glucagon; Humans; Insulin; Kidney Failure, Chronic; Lipolysis; Liver; Male; Middle Aged; Renal Dialysis; Triglycerides; Uremia | 1982 |
Sulfonamide-induced hypoglycemia in chronic renal failure.
Topics: Aged; Alanine; Female; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Heart Failure; Humans; Hydrocortisone; Hypoglycemia; Insulin; Kidney Failure, Chronic; Sulfonamides; Time Factors; Urinary Tract Infections | 1983 |
Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): the effect of a single dialysis cycle.
Topics: Adult; Aged; Alanine; Blood Glucose; Carbohydrates; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Humans; Insulin; Ketone Bodies; Kidney Failure, Chronic; Lactates; Lipids; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Pyruvates | 1983 |
[Endocrine function of the pancreas in patients with acute and chronic renal failure].
Topics: Acute Kidney Injury; Adult; Female; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Kidney Failure, Chronic; Male; Middle Aged; Pancreatic Polypeptide | 1983 |
Metabolism of polypeptide hormones by the kidney.
Topics: Animals; Calcitonin; Dogs; Glomerular Filtration Rate; Glucagon; Hormones; Humans; In Vitro Techniques; Insulin; Kidney; Kidney Failure, Chronic; Metabolic Clearance Rate; Molecular Weight; Parathyroid Hormone; Rats; Uremia | 1980 |
Factors affecting nutrition and growth in uraemic children.
Topics: Blood Glucose; Child; Glucagon; Growth Disorders; Growth Hormone; Humans; Kidney Failure, Chronic; Nutritional Physiological Phenomena; Triglycerides; Uremia | 1980 |
Clinical experience with 15 neoprene-injected pancreatic allotransplants.
Topics: Adult; Creatinine; Diabetes Mellitus; Diabetic Nephropathies; Female; Glucagon; Graft Survival; Humans; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Neoprene; Pancreas Transplantation; Polyenes | 1980 |
Glucose metabolism in patients on continuous ambulatory peritoneal dialysis (CAPD).
Topics: Adult; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory | 1981 |
[Hyperglucagonemia in patients with chronic renal failure treated by repeated hemodialysis].
Topics: Adult; Female; Glucagon; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1980 |
Circulating forms of glucagon and related peptides in normal subjects and uraemic patients.
Topics: Glucagon; Humans; Kidney Failure, Chronic; Molecular Weight; Peptides; Reference Values; Uremia | 1980 |
Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity.
Topics: Adult; Aerobiosis; Aged; Blood Glucose; Cardiac Output; Case-Control Studies; Fatty Acids, Nonesterified; Female; Glomerular Filtration Rate; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Growth Hormone; Hemodynamics; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Oxygen Consumption; Physical Exertion; Reference Values; Stroke Volume; Work Capacity Evaluation | 1995 |
Effects of erythropoietin on glucose tolerance in hemodialysis patients.
Topics: Anemia; Blood Glucose; Erythropoietin; Female; Glucagon; Glucose Tolerance Test; Hemoglobins; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1994 |
Persistence of counter-regulatory abnormalities in insulin-dependent diabetes mellitus after pancreas transplantation.
Topics: Adult; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Glucose; Growth Hormone; Humans; Hypoglycemia; Infusions, Intravenous; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Male; Pancreas Transplantation; Postoperative Period | 1994 |
1% amino acid peritoneal dialysate: single-cycle study in diabetic patients with end-stage renal disease.
Topics: Adult; Amino Acids; Blood Glucose; Diabetic Nephropathies; Dialysis Solutions; Fasting; Female; Glucagon; Glucose; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory | 1994 |
Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation.
Topics: Adult; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Secretion; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Peptide Fragments; Protein Precursors; Radioimmunoassay; Reference Values; Transplantation, Heterotopic | 1993 |
Prediction of glucose tolerance with glucagon stimulation in pancreas transplanted patients.
Topics: Adult; Analysis of Variance; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Kidney Failure, Chronic; Kidney Transplantation; Pancreas Transplantation | 1997 |
Somatostatin release in response to glucose is impaired in chronic renal failure.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Somatostatin; Uremia | 1998 |
Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiency.
Topics: Adult; Binding Sites; Body Mass Index; C-Peptide; Female; Glucagon; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Leptin; Male; Middle Aged; Proteins; Radioimmunoassay; Receptor, IGF Type 1; Receptors, Leptin; Recombinant Proteins | 1998 |
Occult hypoglycemia caused by hemodialysis.
Topics: Blood Glucose; Epinephrine; Glucagon; Hemodialysis Solutions; Humans; Hydrocortisone; Hypoglycemia; Insulin; Kidney Failure, Chronic; Norepinephrine; Renal Dialysis; Time Factors | 1999 |
Intractable hypoglycemia in a patient with diabetes mellitus, bilateral nephrectomy, and chronic active hepatitis.
Topics: Adolescent; Diabetes Mellitus, Type 1; Diagnosis, Differential; Female; Glucagon; Hepatitis B, Chronic; Humans; Hyperinsulinism; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Kidney Failure, Chronic; Nephrectomy; Protein Synthesis Inhibitors; Substance Abuse, Intravenous; Treatment Outcome; Uremia | 2000 |
[Raised cAMP content of striated muscle in experimental chronic renal failure (author's transl)].
Topics: Animals; Catecholamines; Cyclic AMP; Female; Glucagon; Kidney Failure, Chronic; Muscles; Myocardium; Nephrectomy; Parathyroid Hormone; Rats; Uremia | 1975 |
Heterogeneity of plasma glucagon in man.
Topics: Adenoma, Islet Cell; Animals; Diabetes Mellitus; Diabetic Ketoacidosis; Glucagon; Humans; Kidney; Kidney Failure, Chronic; Molecular Weight; Rats | 1976 |
[Circulating types of human glucagon (author's transl)].
Topics: Antibody Specificity; Antigens; Glucagon; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Molecular Weight; Pancreatic Neoplasms | 1978 |
Circulating glucagon. Plasma profiles and metabolism in health and disease.
Topics: Adult; Aged; Animals; Arginine; Bibliographies as Topic; Diabetes Mellitus; Female; Glucagon; Glucose; Humans; Kidney; Kidney Failure, Chronic; Liver; Male; Middle Aged; Molecular Weight; Nephrectomy; Pancreatic Neoplasms | 1977 |
[Influence of glucagon and insulin in the metabolism of lipids in patients under hemodialysis and renal transplants].
Topics: Female; Glucagon; Glucose; Humans; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Lipid Metabolism; Male; Renal Dialysis; Transplantation, Homologous | 1977 |
Response of insulin, glucagon and growth hormone to arginine infusion in patients with chronic renal failure.
Topics: Arginine; Glucagon; Growth Hormone; Humans; Infusions, Parenteral; Insulin; Kidney Failure, Chronic; Renal Dialysis; Time Factors | 1979 |
Effect of renal failure on gastrointestinal hormones.
Topics: Acute Kidney Injury; Cholecystokinin; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Glucagon; Humans; Kidney Failure, Chronic; Secretin | 1979 |
Hyperglucagonaemia and renal failure.
Topics: Animals; Dogs; Glucagon; Humans; Kidney; Kidney Failure, Chronic; Renal Dialysis | 1977 |
Abnormalities in the regulation of growth hormone in chronic renal failure.
Topics: Adult; Blood Glucose; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Hypothalamus; Insulin; Kidney Failure, Chronic; Levodopa; Middle Aged; Pituitary Gland; Renal Dialysis; Stimulation, Chemical; Tolbutamide | 1978 |
[Spontaneous hypoglycemia and chronic kidney insufficiency].
Topics: Adult; Alanine; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Proinsulin; Tolbutamide | 1978 |
[Plasma glucagon responses to L-arginine in various diseases (author's transl)].
Topics: Adolescent; Adult; Aged; Arginine; Chronic Disease; Diabetes Mellitus; Glucagon; Humans; Hyperthyroidism; Kidney Failure, Chronic; Liver Cirrhosis; Middle Aged; Pancreatitis; Time Factors | 1978 |
Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat.
Topics: Animals; Blood Glucose; Disease Models, Animal; Glucagon; Hyperlipidemias; Insulin; Kidney Failure, Chronic; Lipids; Lipoproteins; Male; Nephrectomy; Rats | 1978 |
Hormonal and metabolic responses to intravenous glucose in children on regular hemodialysis.
Topics: Adolescent; Blood Glucose; Child; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Kidney Failure, Chronic; Male; Renal Dialysis | 1978 |
Relationship of plasma lipids to renal function and length of time on maintenance hemodialysis.
Topics: Adult; Aged; Cholesterol; Creatinine; Diabetic Nephropathies; Female; Glucagon; Growth Hormone; Humans; Hyperlipidemias; Insulin; Kidney; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Renal Dialysis; Time Factors; Triglycerides | 1978 |
Study on influence of synthetic glucagon fragment on lymphocyte transformation. I.
Topics: Glucagon; Humans; Kidney Failure, Chronic; Lymphocyte Activation; Peptide Fragments | 1978 |
Elevations of gastrointestinal hormones in chronic renal failure.
Topics: Gastrins; Gastrointestinal Hormones; Glucagon; Humans; Insulin; Kidney Failure, Chronic; Renal Dialysis; Secretin; Vasoactive Intestinal Peptide | 1978 |
[Variations in glycoregulatory factors during hemodialysis].
Topics: Adult; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1978 |
[Surgical diseases of the parathyroid glands (diagnosis and therapy)].
Topics: Adenoma; Calcitonin; Diethylstilbestrol; Edetic Acid; Glucagon; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Kidney Transplantation; Malabsorption Syndromes; Parathyroid Glands; Parathyroid Neoplasms; Peritoneal Dialysis; Prednisone; Renal Dialysis | 1975 |
Renal extraction of glucagon in rats with normal and reduced renal function.
Topics: Animals; Glucagon; Inulin; Kidney; Kidney Failure, Chronic; Male; Rats | 1977 |
Uremic hyperlipoproteinemia: correlation with residual renal function and duration of maintenance hemodialysis.
Topics: Androgens; Cholesterol; Creatinine; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Growth Hormone; Humans; Hyperlipidemias; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors; Triglycerides | 1977 |
Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
Topics: Acetates; Adult; Animals; Antigens; Arginine; Chromatography, Gel; Fasting; Female; Glucagon; Glucose; Humans; Kidney Failure, Chronic; Male; Molecular Weight; Nephrectomy; Rats; Stress, Physiological; Trypsin | 1976 |
Heterogeneity of plasma immunoreactive glucagon.
Topics: Animals; Diabetes Mellitus; Dogs; Ducks; Glucagon; Humans; Hypoglycemia; Immunoglobulin G; Kidney; Kidney Failure, Chronic; Liver Cirrhosis; Mice; Molecular Weight; Phlorhizin | 1976 |
Hyperglucagonemia in uremia: reversal by renal transplantation.
Topics: Cadaver; Creatinine; Glucagon; Graft Rejection; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Tissue Donors; Transplantation, Homologous; Uremia | 1975 |
Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.
Topics: Diabetes Mellitus; Fasting; Glucagon; Humans; Kidney Failure, Chronic; Molecular Weight; Radioimmunoassay | 1976 |
All products of proglucagon are elevated in plasma from uremic patients.
Topics: Acute Kidney Injury; Chromatography, Gel; Female; Glucagon; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peptide Fragments; Proglucagon; Protein Precursors; Reference Values; Uremia | 1992 |
[Adsorption of glucoregulatory hormones by dialysis membrane].
Topics: Acrylic Resins; Adsorption; Blood Glucose; Diabetic Nephropathies; Glucagon; Humans; Insulin; Kidney Failure, Chronic; Membranes, Artificial; Methylmethacrylates; Renal Dialysis; Time Factors | 1991 |
Influence of erythropoietin treatment on glucose tolerance, insulin, glucagon, gastrin and pancreatic polypeptide secretion in haemodialyzed patients with end-stage renal failure.
Topics: Adult; Blood Glucose; Erythropoietin; Gastrins; Gastrointestinal Hormones; Glucagon; Humans; Insulin; Insulin Secretion; Kidney Failure, Chronic; Middle Aged; Pancreatic Polypeptide; Renal Dialysis | 1990 |
The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution.
Topics: Adult; Aged; Amino Acids; Bicarbonates; Blood Glucose; Creatinine; Dialysis Solutions; Female; Glucagon; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Potassium; Urea | 1990 |
Hepatic glucagon metabolism. Correlation of hormone processing by isolated canine hepatocytes with glucagon metabolism in man and in the dog.
Topics: Animals; Cell Membrane; Dogs; Glucagon; Humans; In Vitro Techniques; Kidney Failure, Chronic; Kinetics; Liver; Protein Processing, Post-Translational; Rats; Reference Values; Somatostatin | 1987 |
Effects of naloxone administration on endocrine abnormalities in chronic renal failure.
Topics: Calcitonin; Endocrine System Diseases; Glucagon; Humans; Insulin; Insulin Secretion; Kidney Failure, Chronic; Male; Naloxone; Parathyroid Hormone; Pituitary Hormones, Anterior; Receptors, Opioid | 1987 |
Pancreatic endocrine function in patients treated with ciclosporine, azathioprine and prednisone after kidney transplantation.
Topics: Adult; Azathioprine; Cyclosporins; Female; Glucagon; Humans; Immunosuppression Therapy; Insulin; Kidney Failure, Chronic; Kidney Transplantation; Kinetics; Male; Middle Aged; Pancreas; Pancreatic Polypeptide; Prednisone | 1988 |
Effects of essential amino acids and keto analogues on glucagon secretion in normal subjects and in patients with chronic renal failure.
Topics: Adult; Amino Acids, Essential; Female; Glomerular Filtration Rate; Glucagon; Humans; Keto Acids; Kidney Failure, Chronic; Male; Middle Aged | 1988 |
Does high cortisol in uremic patients influence their glucagon levels?
Topics: Glucagon; Humans; Hydrocortisone; Kidney Failure, Chronic; Renal Dialysis | 1988 |
Effects of chronic renal failure on the regulation of pyruvate kinase.
Topics: Animals; Creatinine; Glucagon; Insulin; Isoenzymes; Kidney Failure, Chronic; Liver; Male; Muscles; Nucleic Acid Hybridization; Pyruvate Kinase; Rats; Rats, Inbred Strains; RNA, Messenger; Uremia | 1987 |
[Characteristics of carbohydrate metabolic disorders and of the secretion of insulin, glucagon and somatotropin in patients with chronic glomerulonephritis and chronic kidney failure].
Topics: Adolescent; Adult; Blood Glucose; Carbohydrate Metabolism; Chronic Disease; Female; Glomerulonephritis; Glucagon; Growth Hormone; Humans; Insulin; Insulin Antibodies; Insulin Secretion; Kidney; Kidney Failure, Chronic; Male; Middle Aged | 1986 |
[Effect of naloxone on insulin and glucagon secretion in patients with chronic renal failure].
Topics: Adult; Female; Glucagon; Humans; Insulin; Insulin Secretion; Kidney Failure, Chronic; Male; Naloxone; Pancreatic Function Tests | 1986 |
[Studies on hyperglucagonemia in renal failure].
Topics: Animals; Glucagon; Glucagon-Like Peptides; Humans; Kidney Failure, Chronic; Male; Nephrectomy; Peptides; Radioimmunoassay; Rats; Rats, Inbred Strains; Renal Dialysis | 1987 |
Hypoglycemia in compensated chronic renal insufficiency. Substrate limitation of gluconeogenesis.
Topics: Alanine; Carbon Radioisotopes; Diabetic Nephropathies; Female; Fluorometry; Glucagon; Gluconeogenesis; Glucose; Glucose Tolerance Test; Humans; Hydroxybutyrates; Hypoglycemia; Insulin; Kidney Failure, Chronic; Lactates; Middle Aged; Radioimmunoassay; Tritium | 1974 |
[Indirect stimulation of the adrenal cortex].
Topics: 11-Hydroxycorticosteroids; Adolescent; Adrenal Glands; Adult; Androgen-Insensitivity Syndrome; Blood Glucose; Child; Child, Preschool; Cushing Syndrome; Dermatomyositis; Gigantism; Glucagon; Humans; Hypothalamo-Hypophyseal System; Hypothyroidism; Insulin; Kidney Failure, Chronic; Middle Aged; Nephrosis; Obesity; Pituitary-Adrenal Function Tests; Tonsillitis | 1972 |
Similar hemodynamic and metabolic responses to ketamine and glucagon.
Topics: Acid-Base Equilibrium; Anesthesia, Intravenous; Blood; Blood Glucose; Blood Pressure; Blood Volume Determination; Carbon Dioxide; Glucagon; Heart Rate; Hemodynamics; Humans; Hydrogen-Ion Concentration; Ketamine; Kidney Failure, Chronic; Lactates; Oxygen; Pyruvates; Renal Dialysis; Serum Albumin, Radio-Iodinated; Time Factors; Vascular Resistance | 1972 |
Comparison of hemodynamic effects of glucagon and ketamine in patients with chronic renal failure.
Topics: Anesthesia; Glucagon; Hemodynamics; Humans; Ketamine; Kidney Failure, Chronic | 1972 |
Spontaneous hypoglycemia associated with chronic renal failure.
Topics: Adult; Aged; Blood Glucose; Dextropropoxyphene; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Kidney Failure, Chronic; Liver Function Tests; Male; Nephrocalcinosis; Nephrosclerosis; Pyelonephritis; Tolbutamide | 1973 |
Hyperglucagonemia of renal failure.
Topics: Adult; Animals; Antigens; Blood Glucose; Blood Urea Nitrogen; Carbohydrate Metabolism; Creatinine; Dietary Proteins; Dogs; Fasting; Glomerulonephritis; Glucagon; Glucose; Humans; Infusions, Parenteral; Insulin; Kidney Failure, Chronic; Middle Aged; Nephrosclerosis; Polycystic Kidney Diseases; Potassium; Renal Dialysis; Serum Albumin; Uremia | 1974 |
Round table discussion: divalent ion metabolism and osteodystrophy in chronic renal failure.
Topics: Animals; Bone Diseases; Calcitonin; Calcium; Fluorides; Glucagon; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Kidney Transplantation; Magnesium; Parathyroid Hormone; Phosphates; Rabbits; Renal Dialysis; Swine; Uremia; Vitamin D | 1969 |
Lipoprotein and carbohydrate disorders in nephrotic syndrome and uremia.
Topics: Adipose Tissue; Blood Glucose; Carbohydrate Metabolism; Cholesterol; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Antagonists; Insulin Resistance; Kidney Failure, Chronic; Lipid Metabolism; Lipoproteins; Liver; Male; Muscles; Nephrotic Syndrome; Protein Biosynthesis; Tolbutamide; Uremia | 1972 |
Glucagon radioimmunoassay: technical problems and recent data.
Topics: Animals; Antibodies; Antibody Specificity; Bile; Chromatography, Paper; Cross Reactions; Cystinosis; Diabetes Mellitus; Glucagon; Immune Sera; Immunoglobulin Fragments; Iodine Isotopes; Kidney Failure, Chronic; Rabbits; Radioimmunoassay; Vertebrates | 1971 |
The blood sugar and serum insulin response to intravenous glucagon in chronic renal failure.
Topics: Adult; Blood Glucose; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Kidney Failure, Chronic; Liver Glycogen; Male; Metabolic Diseases; Middle Aged; Uremia | 1970 |
Intervention of kidney and liver in glucagon catabolism and clearance from plasma.
Topics: Cystinosis; Diabetes Mellitus; Glucagon; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Liver | 1970 |
[Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis: determination of phosphoremia during some dynamic tests].
Topics: Blood Glucose; Carbohydrate Metabolism; Glucagon; Glucose Tolerance Test; Humans; Insulin; Kidney Failure, Chronic; Phosphorus; Renal Dialysis; Tolbutamide; Uremia | 1967 |
Carbohydrate metabolism studies in cirrhosis of the liver.
Topics: Adult; Aged; Blood Glucose; Carbohydrate Metabolism; Diabetes Complications; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; Potassium Deficiency; Sulfobromophthalein; Tolbutamide; Uremia | 1968 |